Event

Alberto Papi

MD
Univ Di Ferrara;Univ Di Ferrara Centro Asma;University of Ferrara

Massimo Corradi

MD
University of Parma;University of Parma, Italy

Nicolas Roche

MD
Hopital Cochin

Hélène Prunier

MSc
Chiesi Farmaceutici

Mario Scuri

MD, PhD
Chiesi Farmaceutici

Montagna Isabella

MSc
Chiesi Farmaceutici

Guasconi Alessandro

MSc
Chiesi Farmaceutici

Géraldine Cohuet

MSc
Chiesi Farmaceutici;Chiesi Farmaceutici SpA;Laboratoires CHIESI SAS

Leonardo M. Fabbri

MD
Univ of Ferrara;University of Ferrara

Stefano Petruzzelli

MD, PhD
Chiesi Farmaceutici;Chiesi Farmaceutici S.p.a.

Stefano Vezzoli

MSc
Chiesi Farmaceutici

Dave Singh

MD, NP
Manchester Academic Health Science Centre, The University of Manchester;Medicines Evaluation Unit (MEU), University of South Manchester NHS Foundation Trust;The University of Manchester, University Ho

Reduction in Fatal Events with ICS-containing Medications: Results of Safety Pooled Analysis from the TRILOGY, TRINITY and TRIBUTE Studies